Platinib Post-Medicare Price and Generic Drug Buying Guide

Pralsetinib (English name: Pralsetinib), trade name Pujihua, is a highly efficient and highly selective RET inhibitor targeted drug jointly developed by Blueprint Medicines and CStone Pharmaceuticals of China. It is mainly used to treat RET gene fusion-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) and RET-mutated medullary thyroid cancer (MTC). With the continuous improvement of medical policies, the medical insurance coverage of platinib and the purchase method of generic drugs have become the focus of patients' attention.

1. Price of platinib after medical insurance

At present, platinib has not been included in China’s medical insurance list, and patients still need to purchase it at their own expense. According to the latest information, the market price of platinib’s original drug is about 20,000 to 30,000 yuan per box, which imposes a heavy financial burden on patients who require long-term treatment. However, with the continuous adjustment of medical policies, platinib may be included in the scope of medical insurance in the future, thus reducing the financial burden on patients. Patients and their families should pay close attention to changes in local medical insurance policies and keep abreast of the medical insurance reimbursement status of platinib.

2. Generic Drug Buying Guide

In view of the high price of the original drug Platinib, many patients choose to purchase generic drugs to reduce their financial burden. Here are some buying guides for generic platinib:

1. Choose formal channels: When purchasing generic drugs, be sure to choose formal channels, such as overseas formal medical institutions. Avoid buying through illegal channels to avoid buying fake or low-quality medicines.

2. Understand the source of the drug: Before purchasing, understand the manufacturer, production batch number, expiration date and other information of the drug to ensure that the source of the drug is reliable.

3. Pay attention to drug quality: Although the price of generic drugs is relatively low, patients still need to pay attention to the quality of the drugs. When purchasing, you can request a drug inspection report or relevant supporting documents.

4. Consult your doctor’s advice: Always consult your doctor before purchasing and using generic drugs. Doctors will recommend appropriate drug specifications and dosage based on the patient's specific conditions.

In summary, Platinib, as a highly effectiveRET inhibitor targeted drug, brings new treatment hope to patients with RET gene fusion or mutant cancers. Although platinib is not currently covered by medical insurance, patients can reduce their financial burden by purchasing generic drugs. When purchasing and using generic drugs, be sure to choose formal channels, understand the source and quality of the drugs, and consult doctors to ensure the safety and effectiveness of the drugs. At the same time, patients should pay close attention to changes in medical insurance policies in order to enjoy discounts on medical insurance reimbursement in a timely manner.